Brickell Biotech to sell additional $15M worth of stock as critical clinical trial begins
BOULDER — Brickell Biotech Inc. (Nasdaq: BBI) is planning to raise an additional $15 million via new stocks and warrants […]
Source: BizWest
Check out market updates
BOULDER — Brickell Biotech Inc. (Nasdaq: BBI) is planning to raise an additional $15 million via new stocks and warrants […]
Source: BizWest